Business, energy, technology, markets and global industry news from Business News Today

NVIDIA BioNeMo

PharmaDeviceNews NVIDIA BioNeMo
Network Bio is working with NVIDIA Corporation to scale a population-level cell-free RNA foundation model aimed at disease detection, biomarker discovery and drug development, highlighting how medical AI could increasingly combine blood-derived molecular signals with large clinical datasets. Representative image.
Medical Devices & Diagnostics

How Network Bio and NVIDIA plan to turn cell-free RNA into disease-spanning medical intelligence

Network Bio and NVIDIA are scaling a cfRNA foundation model for disease detection, biomarker discovery and drug development across biobanks.

Read More
Bristol Myers Squibb is expanding AI drug discovery with NVIDIA Vera Rubin-powered computing infrastructure to support faster, higher-confidence research decisions. Representative image.
Pharma & Biotech

Bristol Myers Squibb is building a vast NVIDIA AI factory, but can it improve drug discovery odds?

Bristol Myers Squibb is scaling NVIDIA-powered drug discovery. Can more computing power deliver faster, higher-confidence pipeline decisions?

Read More